Pfizer
Latest news, explainers and analysis on Pfizer. Tracking 2 stories on Arth Vani.
Connected in the graph
Latest on Pfizer
Pfizer Faces Dual Crisis: Stock Performance Slumps as Iconic Headquarters Decays
Pharmaceutical giant Pfizer is grappling with a significant decline in stock value alongside the physical deterioration of its former landmark building. This trend highlights the company's struggle to maintain its pandemic-era momentum in a post-COVID market.
Global Healthcare Dividends: Why Pfizer Misses the Cut for Top Income Stocks
While healthcare stocks are often seen as safe havens for dividend seekers, recent market shifts have changed the outlook for major players. Experts are highlighting two specific healthcare stocks for their consistent payouts, while cautioning that former favorite Pfizer may no longer be the best choice for income-focused investors.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.